ClinicalTrials.Veeva

Menu

Novel Influenza A (H1N1) Surveillance Registry

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Influenza
H1N1
Novel Influenza A

Study type

Observational

Funder types

NIH

Identifiers

NCT01046331
688
HSN268200536179C (Other Grant/Funding Number)
N01HR056179 (Other Grant/Funding Number)

Details and patient eligibility

About

The demographic characteristics, clinical features, course, and outcomes of severe H1N1 influenza infection requiring intensive care have not been defined rigorously and systematically. While the majority of patients in early reports of critically ill novel influenza A (H1N1) have respiratory involvement, up to 10-20% may present with non-respiratory organ failures, such as shock, seizures, or acute renal failure. The burden of disease and resource utilization of these patients remains largely unknown. The purpose of this surveillance registry is to characterize the demographics, clinical features, outcomes, and resource utilization of patients with H1N1 influenza infection who require intensive care.

Enrollment

894 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admission to an intensive care unit at a participating site with confirmed or suspected Novel H1N1 Influenza infection

Exclusion criteria

  • Influenza-like illness due to non-influenza disease and negative testing for influenza

Trial design

894 participants in 2 patient groups

Adult H1N1
Description:
Patients admitted to adult ICU with confirmed or suspected H1N1 Influence infection
Pediatric H1N1
Description:
Patients admitted to pediatric ICU with confirmed or suspected H1N1 Influenza infection

Trial contacts and locations

86

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems